Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JD9E
|
|||
| Former ID |
DNC007883
|
|||
| Drug Name |
SQ-24798
|
|||
| Synonyms |
2-Mercaptomethyl-5-guanidinopentanoic acid; SQ-24798; CHEMBL236822; 5-carbamimidamido-2-(sulfanylmethyl)pentanoic acid; 69734-02-7; 5-(diaminomethylideneamino)-2-(sulfanylmethyl)pentanoic acid; SQ 24798; SQ 24,798; AC1Q5RYU; AC1L4Y1G; GTPL8656; SCHEMBL5415499; CTK5D1141; BDBM50201438; AKOS030556047; SQ-24,798; 5-guanidino-2-(mercaptomethyl)pentanoic acid; (+/-)-5-guanidino-2-(mercaptomethyl)pentanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H15N3O2S
|
|||
| Canonical SMILES |
C(CC(CS)C(=O)O)CN=C(N)N
|
|||
| InChI |
1S/C7H15N3O2S/c8-7(9)10-3-1-2-5(4-13)6(11)12/h5,13H,1-4H2,(H,11,12)(H4,8,9,10)
|
|||
| InChIKey |
JOVIPJZDTSYNNW-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 69734-02-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carboxypeptidase B2 (CPB2) | Target Info | Inhibitor | [2] |
| KEGG Pathway | Complement and coagulation cascades | |||
| Pancreatic secretion | ||||
| Protein digestion and absorption | ||||
| Panther Pathway | Plasminogen activating cascade | |||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
| WikiPathways | Complement and Coagulation Cascades | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8656). | |||
| REF 2 | 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorg Med Chem Lett. 2007 Mar 1;17(5):1349-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.